Invention Grant
- Patent Title: Spiro-lactam NMDA receptor modulators and uses thereof
-
Application No.: US17108199Application Date: 2020-12-01
-
Publication No.: US11376250B2Publication Date: 2022-07-05
- Inventor: M. Amin Khan
- Applicant: Aptinyx Inc.
- Applicant Address: US IL Evanston
- Assignee: Aptinyx Inc.
- Current Assignee: Aptinyx Inc.
- Current Assignee Address: US IL Evanston
- Agency: Goodwin Procter LLP
- Main IPC: C07D487/10
- IPC: C07D487/10 ; A61K31/499 ; C07D498/10 ; A61P25/02 ; A61P25/04 ; A61K31/5386
Abstract:
Disclosed are compounds having potency in the modulation of NMDA receptor activity. Such compounds can be used in the treatment of conditions such as depression and related disorders. Orally delivered formulations and other pharmaceutically acceptable delivery forms of the compounds, including intravenous formulations, are also disclosed.
Public/Granted literature
- US20210322406A1 SPIRO-LACTAM NMDA RECEPTOR MODULATORS AND USES THEREOF Public/Granted day:2021-10-21
Information query
